Evaluation of TFR2 rs7385804 polymorphism as a genetic marker for hemochromatosis in the pakistani population

Authors

DOI:

https://doi.org/10.14295/bjs.v4i9.718

Keywords:

hemojuveline, hepatocytes, hemochromatosis, hepcidin, ferroprotein

Abstract

Hemochromatosis is an autosomal recessive iron overload disorder. The TFR2 gene variant rs7385804 has been implicated in hemochromatosis, but its role in the Pakistani population remains unexplored. This study intended to examine the association of the TFR2 gene variant rs7385804 with hemochromatosis in Pakistani individuals. We employed a case-control study design, recruiting 200 hemochromatosis patients and 200 healthy controls from the Pakistani population. Deoxyribonucleic acid was isolated from blood samples using the phenol-chloroform method. Sanger sequencing and Tetra-ARMS PCR were used to identify the TFR2 genes and their variant rs7385804. Our results showed a significant association between the TFR2 gene variant rs7385804 and hemochromatosis in the Pakistani population (p < 0.001). The rate of the abnormal alleles was (35%) higher than that of the control (15%). Sanger sequencing confirmed the presence of the variant in 70% of patients, while Tetra-ARMS PCR showed 90% concordance with sequencing results. This study demonstrates the utility of Sanger sequencing and Tetra-ARMS PCR in detecting the TFR2 gene variant rs7385804 in the Pakistani population. Our findings suggest that this variant may serve as a genetic marker for hemochromatosis in this population. More research is required to validate these outcomes and discover the clinical consequences of this association.

References

Adams, P. C., Reboussin, D. M., Barton, J. C., McLaren, C. E., Eckfeldt, J. H., McLaren, G. D., ... & Sholinsky, P. (2005). Hemochromatosis and iron-overload screening in a racially diverse population. New England Journal of Medicine, 352(17), 1769-1778. https://doi.org/10.1056/NEJMoa041534 DOI: https://doi.org/10.1056/NEJMoa041534

Andersen, R. V., Tybjærg-Hansen, A., Appleyard, M., Birgens, H., & Nordestgaard, B. G. (2004). Hemochromatosis mutations in the general population: iron overload progression rate. Blood, 103(8), 2914-2919. https://doi.org/10.1182/blood-2003-10-3564 DOI: https://doi.org/10.1182/blood-2003-10-3564

Bardou-Jacquet, E., Ali, Z. B., Beaumont-Epinette, M. P., Loréal, O., Jouanolle, A. M., & Brissot, P. (2014). Non-HFE hemochromatosis: pathophysiological and diagnostic aspects. Clinics and research in hepatology and gastroenterology, 38(2), 143-154. https://doi.org/10.1016/j.clinre.2013.11.003 DOI: https://doi.org/10.1016/j.clinre.2013.11.003

Barton, J. C., Edwards, C. Q., & Acton, R. T. (2023). HFE hemochromatosis in African Americans: Prevalence estimates of iron overload and iron overload-related disease. The American Journal of the Medical Sciences, 365(1), 31-36. https://doi.org/10.1016/j.amjms.2022.08.015 DOI: https://doi.org/10.1016/j.amjms.2022.08.015

Burke, W., Thomson, E., Khoury, M. J., McDonnell, S. M., Press, N., Adams, P. C., ... & Collins, F. S. (1998). Hereditary hemochromatosis: gene discovery and its implications for population-based screening. Jama, 280(2), 172-178. https://doi.org/10.1001/jama.280.2.172 DOI: https://doi.org/10.1001/jama.280.2.172

Camaschella, C. (2005). Understanding iron homeostasis through genetic analysis of hemochromatosis and related disorders. Blood, 106(12), 3710-3717. https://doi.org/10.1182/blood-2005-05-1857 DOI: https://doi.org/10.1182/blood-2005-05-1857

Clark, P., Britton, L. J., & Powell, L. W. (2010). The diagnosis and management of hereditary haemochromatosis. The Clinical Biochemist Reviews, 31(1), 3.

Cobilinschi, C. O., Săulescu, I., Caraiola, S., Nițu, A. F., Dumitru, R. L., Husar-Sburlan, I., ... & Opriș-Belinski, D. (2023). A “Mix and Match” in Hemochromatosis—A Case Report and Literature Focus on the Liver. Medicina, 59(9), 1586. https://doi.org/10.3390/medicina59091586 DOI: https://doi.org/10.3390/medicina59091586

Costa, T. S., Ferreira, J. M., Couto, M. F., & Nascimento, R. S. (2021). Hereditary hemochromatosis associated with the development of liver cirrhosis. Jornal Brasileiro de Patologia e Medicina Laboratorial, 57, e2842021. https://doi.org/10.5935/1676-2444.20210017 DOI: https://doi.org/10.5935/1676-2444.20210017

Crawford, D. H., Ramm, G. A., Bridle, K. R., Nicoll, A. J., Delatycki, M. B., & Olynyk, J. K. (2023). Clinical practice guidelines on hemochromatosis: Asian Pacific Association for the Study of the Liver. Hepatology International, 17(3), 522-541. https://doi.org/10.1007/s12072-023-10510-3 DOI: https://doi.org/10.1007/s12072-023-10510-3

Crownover, B. K., & Covey, C. J. (2013). Hereditary hemochromatosis. American family physician, 87(3), 183-190.

Fargion, S., Valenti, L., & Fracanzani, A. L. (2011). Beyond hereditary hemochromatosis: new insights into the relationship between iron overload and chronic liver diseases. Digestive and Liver Disease, 43(2), 89-95. https://doi.org/10.1016/j.dld.2010.07.006 DOI: https://doi.org/10.1016/j.dld.2010.07.006

Fernandes, A., Preza, G. C., Phung, Y., De Domenico, I., Kaplan, J., Ganz, T., & Nemeth, E. (2009). The molecular basis of hepcidin-resistant hereditary hemochromatosis. Blood, The Journal of the American Society of Hematology, 114(2), 437-443. https://doi.org/10.1182/blood-2008-03-146134 DOI: https://doi.org/10.1182/blood-2008-03-146134

Finlayson, N. D. (1990). Hereditary (primary) haemochromatosis. BMJ: British Medical Journal, 301(6748), 350. https://doi.org/10.1136/bmj.301.6748.350 DOI: https://doi.org/10.1136/bmj.301.6748.350

Fletcher, L. M., & Powell, L. W. (2003). Hemochromatosis and alcoholic liver disease. Alcohol, 30(2), 131-136. https://doi.org/10.1016/S0741-8329(03)00128-9 DOI: https://doi.org/10.1016/S0741-8329(03)00128-9

Geller, S. A., & Fernando, P. F. de C. (2015). Hereditary Hemochromatosis. Autopsy & Case Reports, 5(1), 7. DOI: https://doi.org/10.4322/acr.2014.043

Gochee, P. A., Powell, L. W., Cullen, D. J., Du Sart, D., Rossi, E., & Olynyk, J. K. (2002). A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation. Gastroenterology, 122(3), 646-651. https://doi.org/10.1016/S0016-5085(02)80116-0 DOI: https://doi.org/10.1016/S0016-5085(02)80116-0

Grosse, S. D., Gurrin, L. C., Bertalli, N. A., & Allen, K. J. (2018). Clinical penetrance in hereditary hemochromatosis: estimates of the cumulative incidence of severe liver disease among HFE C282Y homozygotes. Genetics in Medicine, 20(4), 383-389. https://doi.org/10.1038/gim.2017.121 DOI: https://doi.org/10.1038/gim.2017.121

Hajar, C. G. N., Akhir, S. M., Zefarina, Z., Riffin, N. S. M., Mohammad, T. H. T., Hassan, M. N., ... & Edinur, H. A. (2021). Allelic diversity of the hemochromatosis gene (HFE) in Malays, Chinese and Indians. sexual dysfunction, 3, 4.

Hanson, E. H., Imperatore, G., & Burke, W. (2001). HFE gene and hereditary hemochromatosis: a HuGE review. American journal of epidemiology, 154(3), 193-206. https://doi.org/10.1093/aje/154.3.193 DOI: https://doi.org/10.1093/aje/154.3.193

Jones, D. C., Young, N. T., Pigott, C., Fuggle, S. V., Barnardo, M. C. N. M., Marshall, S. E., & Bunce, M. (2002). Comprehensive hereditary hemochromatosis genotyping. Tissue antigens, 60(6), 481-488. https://doi.org/10.1034/j.1399-0039.2002.600603.x DOI: https://doi.org/10.1034/j.1399-0039.2002.600603.x

Kanwar, P., & Kowdley, K. V. (2013). Diagnosis and treatment of hereditary hemochromatosis: an update. Expert review of gastroenterology & hepatology, 7(6), 517-530. https://doi.org/10.1586/17474124.2013.816114 DOI: https://doi.org/10.1586/17474124.2013.816114

Katsarou, M. S., Papasavva, M., Latsi, R., & Drakoulis, N. (2019). Hemochromatosis: hereditary hemochromatosis and HFE gene. Vitamins and hormones, 110, 201-222. https://doi.org/10.1016/bs.vh.2019.01.010 DOI: https://doi.org/10.1016/bs.vh.2019.01.010

Kontoghiorghes, G. J. (2023). Iron load toxicity in medicine: from molecular and cellular aspects to clinical implications. International journal of molecular sciences, 24(16), 12928. https://doi.org/10.3390/ijms241612928 DOI: https://doi.org/10.3390/ijms241612928

Kowdley, K. V., Brown, K. E., Ahn, J., & Sundaram, V. (2019). ACG clinical guideline: hereditary hemochromatosis. Official journal of the American College of Gastroenterology| ACG, 114(8), 1202-1218. https://doi.org/10.14309/ajg.0000000000000315 DOI: https://doi.org/10.14309/ajg.0000000000000315

Lok, C. Y., Merryweather-Clarke, A. T., Viprakasit, V., Chinthammitr, Y., Srichairatanakool, S., Limwongse, C., ... & Robson, K. J. (2009). Iron overload in the Asian community. Blood, The Journal of the American Society of Hematology, 114(1), 20-25. https://doi.org/10.1182/blood-2009-01-199109 DOI: https://doi.org/10.1182/blood-2009-01-199109

McLaren, C. E., Barton, J. C., Adams, P. C., Harris, E. L., Acton, R. T., Press, N., ... & Thomson, E. (2003). Hemochromatosis and Iron Overload Screening (HEIRS) study design for an evaluation of 100,000 primary care-based adults. The American journal of the medical sciences, 325(2), 53-62. https://doi.org/10.1097/00000441-200302000-00001 DOI: https://doi.org/10.1097/00000441-200302000-00001

Moretti, D., van Doorn, G. M., Swinkels, D. W., & Melse-Boonstra, A. (2013). Relevance of dietary iron intake and bioavailability in the management of HFE hemochromatosis: a systematic review. The American journal of clinical nutrition, 98(2), 468-479. https://doi.org/10.3945/ajcn.112.048264 DOI: https://doi.org/10.3945/ajcn.112.048264

Motulsky, A. G., & Beutler, E. (2000). Population screening in hereditary hemochromatosis. Annual review of public health, 21(1), 65-79. https://doi.org/10.1146/annurev.publhealth.21.1.65 DOI: https://doi.org/10.1146/annurev.publhealth.21.1.65

Padeniya, P., Goonasekara, H., Abeysekera, G., Jayasekara, R., & Dissanayake, V. (2022). Frequency of hereditary hemochromatosis gene (HFE) variants in sri lankan transfusion-dependent beta-thalassemia patients and their association with the serum ferritin level. Frontiers in Pediatrics, 10, 890989. https://doi.org/10.3389/fped.2022.890989 DOI: https://doi.org/10.3389/fped.2022.890989

Paganoni, R., Lechel, A., & Vujic Spasic, M. (2021). Iron at the interface of hepatocellular carcinoma. International Journal of Molecular Sciences, 22(8), 4097. https://doi.org/10.3390/ijms22084097 DOI: https://doi.org/10.3390/ijms22084097

Panigrahi, I. & Ahmad, F. (2007). Evidence for non-HFE linked hemochromatosis in Asian Indians. Indian journal of medical sciences, 60(12), 491-95. DOI: https://doi.org/10.4103/0019-5359.28978

Peesapati, V. S. R., Varanasi, P., Patel, H., & Akella, S. L. (2023). Beyond the Usual Suspects: Hereditary Hemochromatosis and Transaminitis in Primary Care. Cureus, 15(8). https://doi.org/ 10.7759/cureus.43481 DOI: https://doi.org/10.7759/cureus.43481

Pietrangelo, A. (2007). Hemochromatosis: an endocrine liver disease. Hepatology, 46(4), 1291-1301. DOI: https://doi.org/10.1002/hep.21886

Pietrangelo, A. (2010). Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment. Gastroenterology, 139(2), 393-408. https://doi.org/10.1053/j.gastro.2010.06.013 DOI: https://doi.org/10.1053/j.gastro.2010.06.013

Pointon, J. J., Viprakasit, V., Miles, K. L., Livesey, K. J., Steiner, M., O’Riordan, S., ... & Robson, K. J. (2003). Hemochromatosis gene (HFE) mutations in South East Asia: a potential for iron overload☆. Blood Cells, Molecules, and Diseases, 30(3), 302-306. https://doi.org/10.1016/S1079-9796(03)00041-X DOI: https://doi.org/10.1016/S1079-9796(03)00041-X

Savatt, J. M., Johns, A., Schwartz, M. L., McDonald, W. S., Salvati, Z. M., Oritz, N. M., ... & Williams, M. S. (2023). Testing and management of iron overload after genetic screening–identified hemochromatosis. JAMA Network Open, 6(10), e2338995. https://doi.org/10.1001/jamanetworkopen.2023.38995 DOI: https://doi.org/10.1001/jamanetworkopen.2023.38995

Shamas, A. G. (2023). Primary Hereditary Haemochromatosis and Pregnancy. GastroHep, 2023(1), 2674203. https://doi.org/10.1155/2023/2674203 DOI: https://doi.org/10.1155/2023/2674203

The Molecular Pathogenesis of Hereditary Hemochromatosis. (2011). Seminars in liver disease. Thieme Medical Publishers.

Tirnitz-Parker, J. E., Glanfield, A., Olynyk, J. K., & Ramm, G. A. (2013). Iron and hepatic carcinogenesis. Critical Reviews™ in Oncogenesis, 18(5). https://doi.org/10.1615/CritRevOncog.2013007759 DOI: https://doi.org/10.1615/CritRevOncog.2013007759

Van Bokhoven, M. A., van Deursen, C. T. B., & Swinkels, D. W. (2011). Diagnosis and management of hereditary haemochromatosis. Bmj, 342. https://doi.org/10.1136/bmj.c7251 DOI: https://doi.org/10.1136/bmj.c7251

Waalen, J., Nordestgaard, B. G., & Beutler, E. (2005). The penetrance of hereditary hemochromatosis. Best Practice & Research Clinical Haematology, 18(2), 203-220. https://doi.org/10.1016/j.beha.2004.08.023 DOI: https://doi.org/10.1016/j.beha.2004.08.023

Wallace, D. F., & Subramaniam, V. N. (2016). The global prevalence of HFE and non-HFE hemochromatosis estimated from analysis of next-generation sequencing data. Genetics in medicine, 18(6), 618-626. https://doi.org/10.1038/gim.2015.140 DOI: https://doi.org/10.1038/gim.2015.140

Weiss, G. (2010). Genetic mechanisms and modifying factors in hereditary hemochromatosis. Nature reviews Gastroenterology & hepatology, 7(1), 50-58. https://doi.org/10.1038/nrgastro.2009.201 DOI: https://doi.org/10.1038/nrgastro.2009.201

Wessling-Resnick, M. (2017). Iron: Basic nutritional aspects. In Molecular, genetic, and nutritional aspects of major and trace minerals (pp. 161-173). Academic Press. https://doi.org/10.1016/B978-0-12-802168-2.00014-2 DOI: https://doi.org/10.1016/B978-0-12-802168-2.00014-2

Downloads

Published

2025-07-01

How to Cite

Ikhtiar, F., Iqbal, L. Z., Farooq, M. U., Faraz, M. F., Qadir, M. F., Amjad, W., & Nisar, U. A. (2025). Evaluation of TFR2 rs7385804 polymorphism as a genetic marker for hemochromatosis in the pakistani population. Brazilian Journal of Science, 4(9), 24–41. https://doi.org/10.14295/bjs.v4i9.718

Issue

Vol. 4 No. 9 (2025): Brazilian Journal of Science

Section

Health Sciences

License

Copyright (c) 2025 Farhan Ikhtiar, Laraib Zafar Iqbal, Muhammad Usman Farooq, Muhammad Faheem Faraz, Muhammad Faizan Qadir, Warisha Amjad, Ume Aiymen Nisar

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

 

Authors who publish with this journal agree to the following terms:

1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.